Literature DB >> 10529247

Rhodobacter sphaeroides phosphoribulokinase: identification of lysine-165 as a catalytic residue and evaluation of the contributions of invariant basic amino acids to ribulose 5-phosphate binding.

J A Runquist1, D H Harrison, H M Miziorko.   

Abstract

Rhodobacter sphaeroides phosphoribulokinase (PRK) is inactivated upon exposure to pyridoxal phosphate/sodium borohydride, suggesting a reactive lysine residue. Protection is afforded by a combination of the substrate ATP and the allosteric activator NADH, suggesting that the targeted lysine maps within the active site. PRK contains two invariant lysines, K53 and K165. PRK-K53M retains sensitivity to pyridoxal phosphate, implicating K165 as the target of this reagent. PRK-K165M retains wild-type structure, as judged by titration with effector NADH and the tight-binding alternative substrate trinitrophenyl-ATP. The catalytic activity of K165M and K165C mutants is depressed by >10(3)-fold. Residual activity of K165M is insensitive to pyridoxal phosphate, confirming K165 as the target of this reagent. The decreased catalytic efficiency of K165 mutants approaches the effect measured for a mutant of D169, which forms a salt-bridge to K165. K165M exhibits a 10-fold increase in S()1(/)()2 (ATP) and a 10(2)-fold increase in K(m) (Ru5P). To evaluate the contribution to Ru5P binding of K165 in comparison with this substrate's interaction with invariant H45, R49, R168, and R173, PRKs mutated at these positions have been used to determine relative K(i) values for 6-phosphogluconate, a competitive inhibitor with respect to Ru5P. Elimination of the basic side chain of K165, R49, and H45 results in increases in K(m) (Ru5P) which correlate well with the magnitude of increases in K(i) (phosphogluconate). In contrast, while mutations eliminating charge from R168 and R173 result in enzymes with substantial increases in K(m) (Ru5P), such mutant enzymes exhibit only small increases in K(i) (phosphogluconate). These observations suggest that K165, R49, and H45 are major contributors to Ru5P binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529247     DOI: 10.1021/bi9910326

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Arabidopsis and Chlamydomonas phosphoribulokinase crystal structures complete the redox structural proteome of the Calvin-Benson cycle.

Authors:  Libero Gurrieri; Alessandra Del Giudice; Nicola Demitri; Giuseppe Falini; Nicolae Viorel Pavel; Mirko Zaffagnini; Maurizio Polentarutti; Pierre Crozet; Christophe H Marchand; Julien Henri; Paolo Trost; Stéphane D Lemaire; Francesca Sparla; Simona Fermani
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-28       Impact factor: 11.205

2.  Functional evaluation of conserved basic residues in human phosphomevalonate kinase.

Authors:  Timothy J Herdendorf; Henry M Miziorko
Journal:  Biochemistry       Date:  2007-09-29       Impact factor: 3.162

3.  Functional contribution of a conserved, mobile loop histidine of phosphoribulokinase.

Authors:  Jennifer A Runquist; Henry M Miziorko
Journal:  Protein Sci       Date:  2006-03-07       Impact factor: 6.725

4.  A RuBisCO-mediated carbon metabolic pathway in methanogenic archaea.

Authors:  Takunari Kono; Sandhya Mehrotra; Chikako Endo; Natsuko Kizu; Mami Matusda; Hiroyuki Kimura; Eiichi Mizohata; Tsuyoshi Inoue; Tomohisa Hasunuma; Akiho Yokota; Hiroyoshi Matsumura; Hiroki Ashida
Journal:  Nat Commun       Date:  2017-01-13       Impact factor: 14.919

5.  Potential use of sugar binding proteins in reactors for regeneration of CO2 fixation acceptor D-Ribulose-1,5-bisphosphate.

Authors:  Sourav Mahato; Debojyoti De; Debajyoti Dutta; Moloy Kundu; Sumana Bhattacharya; Marc T Schiavone; Sanjoy K Bhattacharya
Journal:  Microb Cell Fact       Date:  2004-06-02       Impact factor: 5.328

6.  Design and in vitro realization of carbon-conserving photorespiration.

Authors:  Devin L Trudeau; Christian Edlich-Muth; Jan Zarzycki; Marieke Scheffen; Moshe Goldsmith; Olga Khersonsky; Ziv Avizemer; Sarel J Fleishman; Charles A R Cotton; Tobias J Erb; Dan S Tawfik; Arren Bar-Even
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-20       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.